Finally, acidosis activated human TRPA1 in pathologies such as myocardial infarction or peripheral vascular occlusive disease [198], but it still has to be proven that targeting TRPA1 could alleviate acidosis evoked-pain in clinical trials [199]. This evidence concerns the gene TRPA1 and thromboangiitis obliterans.